Longmeadow Capital Partners
VC Fund
Stamford, United States
Longmeadow Capital Partners is a venture capital and private equity firm specializing in investments in growth capital, management buyouts.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 29%
- Fund size:
- $15M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Longmeadow Capital Partners invests in
Stages Longmeadow Capital Partners invests in
Countries Longmeadow Capital Partners invests in
Investment Focus
Industry
- Health Care 5 (71%)
- Medical 2 (29%)
- Software 2 (29%)
- Apps 1 (14%)
- SaaS 1 (14%)
Stage
- Series A 3 (43%)
- Seed 1 (14%)
- Series B 1 (14%)
- Series C 1 (14%)
- Funding Round 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Hatch
|
Hatch is the solution that will allow healthcare organizations to finally get every patient in the right place. Patients will receive the best possible care, and healthcare organizations will be able to maximize their growth strategies. | $10M / Series B / Feb 02, 2022 | |
PursueCare
|
PursueCare offers virtual evidence-based addiction treatment for opioids, alcohol, and other substance use disorders, all through a mobile application. The company offers a transitional digital addiction treatment program for patients, particularly those experiencing significant barriers to in-person care, by partnering with health systems,community health partners, employers, and health plans. Patients can also seek treatment without a referral. Founded in 2019, PursueCare is available in Kentucky, Ohio, West Virginia, and all of New England, with national expansion plans. | $4M / Series A / Mar 18, 2020 | |
BioStable
|
BioStable is a cardiovascular device company that develops innovative new products for the treatment of cardiovascular diseases. The company is led by an experienced group of industry executives with expertise in rapid and effective medical device development. The organization incorporates core strengths in all areas of product developmentincluding quality systems, design, engineering, prototyping and pilot production, in-vitro and in-vivo testing, manufacturing, global regulatory relationships, clinical product validation, market launch, and distribution. BioStable provides a competitive edge by minimizing time to market for cost-effective medical devices that deliver improved clinical outcomes. The company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease.BioStable was founded in | Series C / Feb 25, 2020 | |
Lucina Health
|
Lucina Health is a data-driven, enterprise SaaS company that delivers the leading women’s maternity analytics platform to innovative health plans, Medicaid providers and public entities. Lucina Health identifies women at-risk of preterm birth, usually within the first trimester, with personalized health improvement resources, making it easy forcare managers to complete actions that optimize the health and well-being of women to improve birth outcomes and to create healthier communities over time. | $2M / Seed / Mar 25, 2019 | |
IntelyCare
|
IntelyCare offers a digital workforce augmentation platform that combines a gig-model application with advanced data science to optimize staff resources and close the widening gap between workforce supply and demand. IntelyCare is revolutionizing the antiquated healthcare staffing market, filling nursing shifts at three times the industry averageand giving post-acute facilities the tools to predict and manage staffing needs. The company’s engaging mobile app empowers nursing professionals with access to flexible, on-demand work opportunities, reducing burnout and attrition while increasing productivity. | $10.8M / Series A / Nov 01, 2018 | |
|
Hatch
|
Hatch is the solution that will allow healthcare organizations to finally get every patient in the right place. Patients will receive the best possible care, and healthcare organizations will be able to maximize their growth strategies. | Apr 26, 2018 | |
|
Hatch
|
Hatch is the solution that will allow healthcare organizations to finally get every patient in the right place. Patients will receive the best possible care, and healthcare organizations will be able to maximize their growth strategies. | $3.5M / Series A / May 02, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Longmeadow Capital Partners invest in?
Longmeadow Capital Partners invests primarily in Health Care, Medical and Software startups, most often at Series A and Seed stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Longmeadow Capital Partners last invest?
The most recent investment recorded for Longmeadow Capital Partners closed in Feb 2022. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
